Table 1.
Correlation between miR-211 expression and the clinicopathological parameters
| Variables | Number | miR-211 expressiona
|
P-valueb | |
|---|---|---|---|---|
| Low (n=12) |
High (n=28) |
|||
| Age (years) | 0.293 | |||
| ≥50 | 22 (55.0%) | 7 (17.5%) | 15 (37.5%) | |
| <50 | 18 (45.0%) | 5 (12.5%) | 13 (32.5%) | |
| Gender | 0.070 | |||
| Male | 23 (57.5%) | 6 (15.0%) | 17 (42.5%) | |
| Female | 17 (42.5%) | 6 (15.0%) | 11 (27.5%) | |
| Tobacco smoking status | 0.038 | |||
| Nonsmoker | 23 (57.5%) | 8 (20.0%) | 15 (37.5%) | |
| Smoker | 17 (42.5%) | 4 (10.0%) | 13 (32.5%) | |
| Tumor size (cm) | 0.025 | |||
| ≥5 | 20 (50.0%) | 8 (20.0%) | 12 (30.0%) | |
| <5 | 20 (50.0%) | 4 (10.0%) | 16 (40.0%) | |
| Alcohol drinking status | 0.144 | |||
| Nondrinker | 23 (57.5%) | 7 (17.5%) | 16 (40.0%) | |
| Drinker | 17 (42.5%) | 5 (12.5%) | 12 (30.0%) | |
| Tumor stage | 0.022 | |||
| I–II | 15 (37.5%) | 6 (15.0%) | 9 (22.5%) | |
| III | 25 (62.5%) | 6 (15.0%) | 19 (47.5%) | |
Notes:
a
Relative expression of miR-211 was determined using the 2−ΔΔct method, and the median of 2−ΔΔct was used to divide all patients into groups based on high expression of miR-211 or low expression of miR-211.
b
χ2 test.
Abbreviation: miR-211, microRNA-211.